Week 11 Dispatch: The Machine Economy Takes Shape
Pentagon politics, 84% longer mouse lives, and China's first approved brain chip
This was one of those weeks where every sector on the convergence watchlist moved at once. Here’s what happened.
Anthropic Finds Itself at War With the Pentagon
On Wednesday, Pentagon CTO Emil Michael told CNBC that Anthropic’s Claude models would “pollute” the defense department’s supply chain because they have “a different policy preference” baked in. The same day, Anthropic launched its $100 million Claude Partner Network. And TIME ran a cover story calling the company “the most disruptive in the world.”
The whiplash is instructive. Foundation models are now treated as strategic assets, and governments are picking sides. For investors, this creates a new category of regulatory risk that didn’t exist two years ago. It doesn’t matter whether you agree with the Pentagon’s reasoning. What matters is that the risk is real and will likely grow.
Anthropic’s $380 billion valuation puts it ahead of Goldman Sachs and Coca-Cola. The company is using Claude to help build more advanced versions of itself. If that doesn’t keep you up at night, you haven’t been paying attention.
NVIDIA GTC Starts Monday. Expect Fireworks.
Jensen Huang promised “chips the world has never seen before.” What we know: the Vera Rubin superchip combines GPU and CPU with HBM4 memory, built specifically for autonomous agents that navigate complex software environments without human help. The Feynman chip is NVIDIA’s first dedicated inference architecture, separate from training.
This distinction matters. Training was phase one of the AI buildout. Inference, where models think and act in real time, is phase two. NVIDIA is building the hardware for an economy where software agents work around the clock, pay for services, and manage resources autonomously.
AI investments are projected to drive roughly 40% of total US GDP growth in 2026. The largest technological contribution to the economy since the internet.
“AI Agents Will Outnumber Humans in Financial Transactions”
Both Brian Armstrong (Coinbase) and Changpeng Zhao (Binance) said the same thing this week: AI agents will soon conduct more financial transactions than people. Banks can’t serve them because identity verification doesn’t work for software. Crypto does.
Coinbase’s Agentic Wallets and x402 payment protocol are already live and processing. OKX launched an AI upgrade to its OnchainOS platform that lets agents operate autonomously across 60+ blockchains. This is the convergence thesis playing out in real time: AI creates the demand, crypto provides the infrastructure.
Cerebras Heads for IPO
The NVIDIA challenger has tapped Morgan Stanley to lead its initial public offering, targeting $2 billion at a $23 billion valuation. Seeking Alpha reports a $10 billion deal with OpenAI and confirms Cerebras rejected an acquisition attempt by NVIDIA. The IPO is expected in Q2.
Oklo and Centrus Build the Nuclear Fuel Chain
Oklo and Centrus Energy announced a planned joint venture for nuclear fuel services in Pike County, Ohio, co-located with Oklo’s planned 1.2 GW power campus. The goal: a centralized hub for HALEU fuel that serves the entire advanced reactor industry.
There’s plenty of talk about AI’s energy needs. Oklo is building. That difference separates winners from bystanders.
Immorta Bio: Mice Lived 84% Longer
The most striking result of the week comes from longevity biotech. Immorta Bio reported an 84% extension of median lifespan in mice using a two-pronged approach: SenoVax, an immunotherapy that trains the immune system to eliminate senescent “zombie” cells, combined with personalized stem cells from their StemCellRevivify platform.
Mice aren’t people. But these numbers are strong enough that the research has been accepted for presentation at the AAI annual meeting in Boston next month. The company is preparing for human clinical trials, initially targeting liver disease and cancer.
China Approves Its First Implantable Brain Chip
On March 13, Neuracle Medical Technology received China’s first regulatory approval for an implantable brain-computer interface. The system is designed to restore hand motor function in patients with spinal cord injuries.
The US-China BCI race now has regulatory milestones on both sides. Neuralink is preparing for mass production. Neuracle has approval. A leading Chinese BCI expert told Reuters that the technology could reach broad public use within three to five years.
DeepSeek V4: Still Waiting
Five announced release windows have come and gone. On March 9, something called “V4 Lite” appeared, a 1-trillion-parameter multimodal model with open weights. DeepSeek said nothing about it. The full V4 is still expected and is rumored to handle text, images, and video in a single model.
NuScale Power Under Pressure
NuScale’s stock sits at $12.38, well below its highs. On the positive side, Framatome expanded its partnership to fabricate NRC-approved SMR fuel at both European and US facilities. On the negative side, multiple securities fraud class action lawsuits have been filed, with a lead plaintiff deadline of April 20.
Market Snapshot
Bitcoin trades around $70,000 with the Fear and Greed Index at 13, deep in “extreme fear” territory. Ethereum holds at $2,050 with a triple oversold signal. Total crypto market cap sits at roughly $2.3 trillion. Institutional buyers appear to view $70,000 as a fair value zone rather than a peak.
$1.9 billion in BTC options expired today.
Week Ahead
NVIDIA GTC runs March 16-19, and every chip announcement will ripple through the AI supply chain. DeepSeek V4 remains imminent. Cerebras is meeting with investors ahead of its IPO. And the EU AI Act’s high-risk deadline in August 2026 continues to approach, with the second draft of the code of practice on AI-generated content labeling published last week.
The convergence keeps accelerating. AI builds the brain. Robotics builds the body. Crypto builds the wallet. Energy powers it all. And biotech is working on making sure we’re around to see how it plays out.